Cihan Ay
@cihanaymd.bsky.social
Professor of Hematology #Thrombosis and #Hemostasis
🫁 Can #particulatematter and #airpressure trigger #pulmonaryembolism? Researchers from #MedUniVienna analysed 969 cases and links to short-term environmental conditions in @rpth.bsky.social. ⬇️ @cihanaymd.bsky.social
More pulmonary embolism diagnoses with higher levels of particulate matter and air pressure
More about the analysis!
meduniwien.ac.at
What awaits you at the #ISTH2026 Congress & why should you submit abstracts & participate? In the latest @ISTH.org Pulse podcast W. Ageno 🇮🇹 @cihanaymd.bsky.social 🇦🇹 & host @gbarnesmd.bsky.social 🇺🇸 go behind the scenes of the congress preps. 🎧Listen & join the journey to Paris 🇫🇷: bit.ly/48PRg9a
Can AI match the expertise of leading thrombosis specialists? In our newest ISTH Pulse Podcast episode, Nikola Vladic shares findings from his groundbreaking study in @jthjournal.bsky.social comparing large language models to human experts in patient care and education. 🎧 Listen: bit.ly/3X9FMH4
⏰ Tomorrow is #WorldThrombosisDay! ✍️ One simple way to get involved: Sign the World Thrombosis Day Pledge! Show your commitment to spreading awareness and preventing thrombosis worldwide. 🔗 Take the pledge now: bit.ly/3WANzgI
🚀 AI vs. Thrombosis Experts: Who performs better? New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases. @nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
Large language models versus thrombosis experts: A comparative study on patient education and clinical decision-making in venous thromboembolism
Large language models (LLMs) have demonstrated remarkable capabilities in various medical fields, yet their performance in thrombosis and haemostasis, particularly in patient education and complex cli...
jthjournal.org
Our Annual Congress Planning Committee (ACPC) is hard at work in Paris this week, laying the groundwork for an unforgettable #ISTH2026! The best is yet to come! Learn more here: www.isthcongress.org
Really great state-of-the-art talk by Julia Riedl on the role of podoplanin in brain cancer-assiciated thrombosis #ISTH2025
Great work by Hoberstorfer from Vienna 👏Unfortunately, machine learning of #cancer-associated thrombosis prediction didn’t outperform current models. Showing how complex CAT is #ISTH2025 @cihanaymd.bsky.social
Check out the late-breakthrough abstracts - featuring cutting-edge data from major clinical trials & game-changing studies - to be presented at the @ISTH.org #ISTH2025 congress starting on June 21. It is not too late to register and participate in person or on-demand! Learn more: bit.ly/4jI5oDL
Introducing: The ISTH Congress Attendee Starter Pack loaded with essentials for an epic #ISTH2025, including: ✅Endless enthusiasm from @guyyoungmd.bsky.social ✅A refillable coffee cup ✅A tote bag stuffed with 17 pens Register now: www.isth2025.org and tell us what’s a must-have in your starter pack?
Big congrats to Stephan Nopp on his successful PhD defense! 🎓👏 It was a real pleasure working with you – smart, dedicated, and a true team player. Wishing you all the best for what’s next!
We have successfully treated the first patient with #hemophilia B in Austria at the beginning of April - truly a "game changer" for people with hemophilia. Grateful to live in a country where innovative treatments like this are accessible, offering new hope for the future.
MedUni Wien@meduniwien.ac.at · last yr.⭕️ New type of #genetherapy to treat the severe form of #haemophilia B ⤵️ The treatment for the hereditary #bloodclotting disorder needs to be administered once as an intravenous infusion & is effective for years. ⬇️ @cihanaymd.bsky.social
@acc25.bsky.social Isabelle Mahe presents API-CAT Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
Prof. @isabellemahe.bsky.social presents API-CAT at @accintouch.bsky.social published in @nejm.org: Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in cancer patients www.nejm.org/doi/full/10....
📢 @jthjournal.bsky.social is proud to announce the recipients of the 2025 JTH Editors’ Awards! These prestigious awards honor six outstanding early career investigators for their top articles in thrombosis and hemostasis. Join us in congratulating the winners🎉 and learn more here: bit.ly/4lc2pFR
Postpartum hemorrhage is a significant risk for many women yet the etiology is not well understood. New study from Claire de Moreuil shows that plasma from PPH have a different fibrin network than controls. www.rpthjournal.org/article/S247... @aswolberg.bsky.social @cihanaymd.bsky.social
Exited to share our latest research on biological aging in #hemophilia, an inherited bleeding disorder with significant improvements in life expectancy over the last decades. Our results indicate an accelerated biological aging in people with hemophilia. Access to paper: doi.org/10.3324/haem...
Air pollution and venous thromboembolism Our commentary on the study published by Dr. Lutsey et al. in @bloodjournal.bsky.social reporting that greater long-term exposure to air pollution is associated with higher risk of developing VTE. doi.org/10.1182/bloo... ashpublications.org/blood/articl...
Air pollution and venous thromboembolism
Although the visible smog of air pollution is concerning, its hidden dangers to human health are even more alarming. In this issue of Blood, Lutsey et al h
ashpublications.org
📰 New article available #openaccess Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study Acute pulmonary embolism is rare during childhood and adolescence @mainzuniversity.bsky.social @cihanaymd.bsky.social tinyurl.com/2avwapcr
Updates on risk assessment and prevention of cancer-associated #thrombosis in ambulatory patients with #cancer. Excellent overview in a State-of-the-Art Review by @nikola-vladic.bsky.social published in @rpth.bsky.social @worldthrombosisday.bsky.social www.rpthjournal.org/article/S247...
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
Venous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of...
rpthjournal.org
End-of-the-year get-together at the Christmas dinner/party of our Thrombosis and Haemostasis Research Group in Vienna. Happy, proud & grateful what the team has achieved this year with many contributions to science & education. Thank you to each team member - looking forward to continue our work!
